Patent directory · USPTO A61K / A61P
Patents matching “therapy”
782 pharma patents match "therapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 782 pharmaceutical patents matching "therapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 6387959
Antiviral therapy
expired -
US 6380167
Methods for anti-tumor therapy
expired -
US 6376483
Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production
expired -
US 6365164
Use of neurotoxin therapy for treatment of urologic and related disorders
expired -
US 6342390
Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy
expired -
US 6342216
Therapy of cancer by insect cells containing recombinant baculovirus encoding genes
expired -
US 6335010
Gene therapy in coronary angioplasty and bypass
expired -
US 6323019
Design of novel highly efficient HIV based packaging systems for gene therapy
expired -
US 6306830
Gene therapy for congestive heart failure
expired -
US 6299873
Method for improvement of radiation therapy of malignant tumors
expired -
US 6287537
Radioimmunotherapy of lymphoma using anti-CD20 antibodies
expired -
US 6284242
Method for enhancing myoblast migration and invasion in the context of gene therapy
expired -
US 6277368
Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine
expired -
US 6265539
Prophylaxis and therapy of acquired immunodeficiency syndrome
expired -
US 6261831
Ultra-wide band RF-enhanced chemotherapy for cancer treatmeat
expired -
US 6251871
P16 expression constructs and their application in cancer therapy
expired -
US 6248916
Macromolecular structures for boron neutron-capture therapy
expired -
US 6245561
.beta.-alethine use in cell culture and therapy
expired -
US 6224866
Immunotherapy of B cell involvement in progression of solid, nonlymphoid tumors
expired -
US 6225290
Systemic gene therapy by intestinal cell transformation
expired -
US 6207147
Cancer immunotherapy using tumor cells combined with mixed lymphocytes
expired -
US 6204000
Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1
expired -
US 6190656
Immunologic enhancement with intermittent interleukin-2 therapy
expired -
US 6183752
Restenosis/atherosclerosis diagnosis, prophylaxis and therapy
expired